Search research articles
Contact Us
Filters
Showing results (311-320 of 382) with videos related to
Page
of 39
Sort By:
American Journal of Hematology
|
February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
N Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
European Journal of Haematology
|
January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Blood Cancer Journal
|
April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Nirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Leukemia
|
October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Blood Cancer Journal
|
December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Nirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Bone Marrow Transplantation
|
September 5, 2017
A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
A Dispenzieri, A D'Souza, M A Gertz, et al.
The Journal of Surgical Research
|
July 30, 2025
Qualitative Analysis of Program Director Perspectives on Conscientious Objection Policies to Gender-Affirming Care
Rebecca Arteaga, Danielle J Eble, Alisha L Nguyen, et al.
Leukemia & Lymphoma
|
January 12, 2018
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma
Mohamad Bassam Sonbol, Talal Hilal, Amylou C Dueck, et al.
Mayo Clinic Proceedings
|
October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
Morie A Gertz, Stephen M Ansell, David Dingli, et al.
American Journal of Hematology
|
June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
Angela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Page
of 39
Search research articles
Search
Showing results (311-320 of 382) with videos related to
Sort By:
Page
of 39
American Journal of Hematology
|
February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma
N Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
European Journal of Haematology
|
January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome
Angela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Blood Cancer Journal
|
April 30, 2021
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Nirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Leukemia
|
October 14, 2018
Primary systemic amyloidosis in patients with Waldenström macroglobulinemia
Saurabh Zanwar, Jithma P Abeykoon, Stephen M Ansell, et al.
Blood Cancer Journal
|
December 5, 2019
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Nirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Bone Marrow Transplantation
|
September 5, 2017
A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma
A Dispenzieri, A D'Souza, M A Gertz, et al.
The Journal of Surgical Research
|
July 30, 2025
Qualitative Analysis of Program Director Perspectives on Conscientious Objection Policies to Gender-Affirming Care
Rebecca Arteaga, Danielle J Eble, Alisha L Nguyen, et al.
Leukemia & Lymphoma
|
January 12, 2018
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma
Mohamad Bassam Sonbol, Talal Hilal, Amylou C Dueck, et al.
Mayo Clinic Proceedings
|
October 3, 2008
Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative
Morie A Gertz, Stephen M Ansell, David Dingli, et al.
American Journal of Hematology
|
June 1, 2010
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma
Angela Dispenzieri, Gregory A Wiseman, Martha Q Lacy, et al.
Page
of 39